Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
about
The emergent reversal of coagulopathies encountered in neurosurgery and neurology: a technical noteEvaluation of bleeding complications associated with glycoprotein IIb/IIIa inhibitorsEptifibatide-associated acute, profound thrombocytopenia.Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.Successful percutaneous coronary intervention using bivalirudin in a patient with chronic lymphocytic leukemia and thrombocytopenia.First report of tirofiban-induced anemia (found in combination with severe thrombocytopenia).Thrombocytopenia following percutaneous coronary intervention.Safety evaluation of tirofiban.The Successful Use of Enoxaparin in the Lack of Bivalirudin in a Patient with Chronic Lymphocytic Leukemia and Thrombocytopenia who Underwent Percutaneous Coronary Revascularization.Rising like the phoenix?Glycoprotein IIb/IIIa inhibitors in patients with end-stage renal disease.Tirofiban in acute coronary syndromes.Integrin αIIbβ3: from discovery to efficacious therapeutic targetChemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: A review.Managing adverse effects and drug-drug interactions of antiplatelet agents.Review of Currently Available GP IIb/IIIa Inhibitors and Their Role in Peripheral Vascular Interventions.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Why we need intravenous antiplatelet agents.Use of GPIIb/IIIa inhibitors in cardiovascular medicine.Use of antiplatelet inhibitors in peripheral vascular interventions.The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrations.Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series.Requirements for emergent neurosurgical procedures among patients undergoing neuroendovascular procedures in contemporary practice.
P2860
Q27014959-51DCA5DC-45AA-4D14-B16B-60460F2B8AB6Q28213564-66CA9604-1256-4D83-B033-399FA2551718Q33364492-DEC6C7D1-E273-46AC-A458-487B141B5948Q33369310-E345C009-BE4B-4B34-8F19-D6550CB00769Q33372584-4EDDAD78-3C9F-449C-B318-2071E7E57B4EQ33384473-6EC2FB82-8938-4E3B-AE12-F02A0F4C4C9FQ33387648-230B883F-0FF1-473B-9BD6-42A7D60610A5Q33391065-060D6E98-5358-453A-8C54-87A4431EE4B6Q33419923-E5519BC3-CEAC-4406-9F94-ACB1A5609F13Q34347772-2E1B55AA-0446-48A9-BE1C-A9249A52BF60Q36053248-12EC7BF5-AF37-4511-9195-EEC1FA1979C0Q36107187-A5EA12BC-65B5-4193-A1BD-D69C8E10ECA7Q37011736-FDDF27F4-0052-4421-AE84-1EEB9CAEFD41Q37431543-B48ECA4B-5FE6-4E51-B948-D1CA8DF98831Q37930967-C5C60480-7CCC-4D1D-950F-C4EC3EC354C9Q38006947-0E3C79EB-0125-468F-B984-C39E94F99A75Q38087506-72444566-17BC-4CF5-AA89-1DBC455B199DQ38657846-9B6213BF-823F-43E1-B361-DE434EC5D17EQ38851769-AB041BE0-04FA-43C2-AEBC-33D6412E5524Q40523922-2CC6E017-B255-47D8-8D74-FCF2A97D1EF0Q42118681-62979E9D-C03B-4393-91B1-1C79F80FF781Q43178534-1ACC9D18-D8A7-4EE8-9704-CBF9E154651BQ44699573-6726045F-3BD4-4EF5-A738-BC1B0176D273Q44939880-C4996096-46C8-4BED-A591-93C32A0C5588
P2860
Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@ast
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@en
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@nl
type
label
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@ast
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@en
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@nl
prefLabel
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@ast
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@en
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@nl
P356
P1476
Clinical challenges of platele ...... mbocytopenia, and retreatment.
@en
P2093
J E Tcheng
P304
P356
10.1067/MHJ.2000.103742
P407
P433
P577
2000-02-01T00:00:00Z